| SAVA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SAVA market cap history going back to 10/26/2018:
Also see: SAVA Shares Outstanding History and SAVA YTD Return |
SAVA Market Cap History — Cassava Sciences Capitalization Over Time
As of 3/9/2026 Cassava Sciences has a market cap of 102.41 million. Investors often follow the SAVA market cap history to compare the size of the company over time.
This page shows SAVA market capitalization trends over time, with 30 market cap datapoints presented, dating back to 10/26/2018.
| SAVA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SAVA Historical Market Cap: +23.97% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SAVA Stock Price Chart |
| About Cassava Sciences Inc |
| Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. Co.'s science is based on stabilizing, but not removing, a critical protein in the Alzheimer's brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer's disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer's brain. We show 30 historical shares outstanding datapoints in our SAVA shares outstanding history coverage, used to compute SAVA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SAVA market cap history over the course of time is important for investors interested in comparing SAVA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SAVA versus a peer is one thing; comparing SAVA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SAVA can fluctuate over the course of history. With this page we aim to empower investors researching SAVA by allowing them to research the SAVA market cap history. |
| SAVA Current Stock Quote |
Quotes delayed 20 minutes  Free SAVA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SAVA Share Performance |
| Market Cap Peers |
| Cassava Sciences (SAVA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SBFM Market Cap History SBPH Market Cap History SBTX Market Cap History SCPH Market Cap History SCPS Market Cap History SCTL Market Cap History SCYX Market Cap History SDC Market Cap History SDGR Market Cap History SEEL Market Cap History More Healthcare companies » |
SAVA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
